You signed in with another tab or window. Reload to refresh your session.You signed out in another tab or window. Reload to refresh your session.You switched accounts on another tab or window. Reload to refresh your session.Dismiss alert
{{ message }}
This repository was archived by the owner on Feb 7, 2023. It is now read-only.
I have been working with the National Institute for Communicable Diseases (NICD) on some of their SARS-CoV-2 sequencing. I adapted the "variation" workflow to call variants in Illumina data and also produce an inferred consensus genome. The current "Assembly" workflow assumes that you have access to both Illumina and Nanopore genomes for a sample, which is a pretty rare situation. My workflow (with some TODOs in the step annotation) is in a gist. Comments and additions are welcome!
If it is found to be useful perhaps it can be incorporated into the COVID-19 resources page.
P.S. for those with ARTIC Amplicon data I created a workflow for analysing that as did Thanh le Viet. Pasting them here in case they are useful.
Hi everyone
I have been working with the National Institute for Communicable Diseases (NICD) on some of their SARS-CoV-2 sequencing. I adapted the "variation" workflow to call variants in Illumina data and also produce an inferred consensus genome. The current "Assembly" workflow assumes that you have access to both Illumina and Nanopore genomes for a sample, which is a pretty rare situation. My workflow (with some TODOs in the step annotation) is in a gist. Comments and additions are welcome!
If it is found to be useful perhaps it can be incorporated into the COVID-19 resources page.
P.S. for those with ARTIC Amplicon data I created a workflow for analysing that as did Thanh le Viet. Pasting them here in case they are useful.